Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
23.69
+0.33 (1.41%)
At close: Apr 28, 2026, 4:00 PM EDT
23.70
+0.01 (0.04%)
After-hours: Apr 28, 2026, 7:42 PM EDT
Innoviva Market Cap
Innoviva has a market cap or net worth of $1.75 billion as of April 28, 2026. Its market cap has increased by 63.68% in one year.
Market Cap
1.75B
Enterprise Value
1.52B
1-Year Change
63.68%
Ranking
Category
Stock Price
$23.69
Market Cap Chart
Since October 5, 2004, Innoviva's market cap has increased from $743.40M to $1.75B, an increase of 135.98%. That is a compound annual growth rate of 4.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.73B | 15.78% |
| Dec 31, 2025 | 1.49B | 37.61% |
| Dec 31, 2024 | 1.09B | 5.65% |
| Dec 29, 2023 | 1.03B | 11.18% |
| Dec 30, 2022 | 924.60M | -22.87% |
| Dec 31, 2021 | 1.20B | -4.58% |
| Dec 31, 2020 | 1.26B | -12.40% |
| Dec 31, 2019 | 1.43B | -18.66% |
| Dec 31, 2018 | 1.76B | 15.03% |
| Dec 29, 2017 | 1.53B | 31.74% |
| Dec 30, 2016 | 1.16B | -6.00% |
| Dec 31, 2015 | 1.24B | -24.18% |
| Dec 31, 2014 | 1.63B | -48.60% |
| Dec 31, 2013 | 3.18B | 81.10% |
| Dec 31, 2012 | 1.75B | 15.68% |
| Dec 30, 2011 | 1.52B | 16.20% |
| Dec 31, 2010 | 1.30B | 94.91% |
| Dec 31, 2009 | 669.40M | 8.40% |
| Dec 31, 2008 | 617.50M | -35.48% |
| Dec 31, 2007 | 957.00M | -35.96% |
| Dec 29, 2006 | 1.49B | 30.34% |
| Dec 30, 2005 | 1.15B | 49.85% |
| Dec 31, 2004 | 765.10M | 2.92% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.86B |
| Syndax Pharmaceuticals | 1.85B |
| Palvella Therapeutics | 1.84B |
| Recursion Pharmaceuticals | 1.84B |
| Harmony Biosciences Holdings | 1.80B |
| Sionna Therapeutics | 1.76B |
| Vir Biotechnology | 1.72B |
| Nurix Therapeutics | 1.71B |